Zobrazeno 1 - 5
of 5
pro vyhledávání: '"E V, Budankova"'
Autor:
N V, Solenkova, L N, Maslov, E V, Budankova, A Iu, Lishmanov, P, Oeltgen, M, Govindaswami, Zh D, Bespalova, M V, Ovchinnikov, H, Nagaze
Publikováno v:
Eksperimental'naia i klinicheskaia farmakologiia. 68(6)
It has been established that pretreatment with the selective mu-opioid receptor (OR) agonist DALDA (0.1 mg/kg, i.v.) or the selective delta1-OR agonists DPDPE (0.09 mg/kg) and/or (-)-TAN-67 (0.08 mg/kg) has no effect on the incidence of ventricular a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::7c8a15200a32a6850add0286fb4fbedb
https://pubmed.ncbi.nlm.nih.gov/16405030
https://pubmed.ncbi.nlm.nih.gov/16405030
Autor:
L N, Maslov, A Iu, Liishmanov, E V, Budankova, D L, Stakheev, N V, Solenkova, E I, Barzakh, P R, Oeltgen, G J, Gross, W S, Chang
Publikováno v:
Izvestiia Akademii nauk. Seriia biologicheskaia. (4)
Preliminary selective blockade of micro, delta1, delta2, kappa1, and kappa2 opioid receptors proved to have no effect on the incidence of ventricular arrhythmias during a 10-min coronary occlusion and subsequent reperfusion in ketamine-anesthetized r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::82c6b2f1467212604a1ee58aabab17e6
https://pubmed.ncbi.nlm.nih.gov/16212267
https://pubmed.ncbi.nlm.nih.gov/16212267
Autor:
L N, Maslov, A Iu, Lishmanov, N V, Solenkova, E V, Budankova, T M, Wong, W C, Chang, L X, Bray
Publikováno v:
Eksperimental'naia i klinicheskaia farmakologiia. 68(1)
Pretreatment with a selective kappa1 opioid receptor (OR) agonist (-)-U-50,488 (1 mg/kg, i.v.) prevented the development of arrhythmias induced by occlusion (10 min) and reperfusion (10 min) in ketamine anesthetized rats, while the treatment with a l
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::a20da10968342c0ae9de661bffd4539f
https://pubmed.ncbi.nlm.nih.gov/15786960
https://pubmed.ncbi.nlm.nih.gov/15786960
[Changes in cardiac resistance to arrhythmogenic effects during ATP-dependent K+ channel activation]
Autor:
S A, Bogomaz, L N, Maslov, A V, Krylatov, N V, Solenkova, A Iu, Lishmanov, E V, Budankova, G J, Grover
Publikováno v:
Rossiiskii fiziologicheskii zhurnal imeni I.M. Sechenova. 89(4)
It has been found that pretreatment with ATP-dependent potassium channel (KATP-channel) opener, BMS 180448 (3 mg/kg, intravenously), increases cardiac resistance against arrhythmogenic action of coronary artery occlusion and reperfusion in anaestheti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::e6ad2debdd2dd17f387f9585e0ed79c9
https://pubmed.ncbi.nlm.nih.gov/12966718
https://pubmed.ncbi.nlm.nih.gov/12966718
Autor:
L. N. Maslov, Yu. B. Lishmanov, N. V. Naryzhnaya, E. V. Budankova, D. L. Stakheev, N. V. Solenkova, E. I. Barzakh, P. R. Oeltgen, G. J. Gross
Publikováno v:
Bulletin of Experimental Biology & Medicine; Feb2005, Vol. 139 Issue 2, p172-175, 4p